Clinical Trial Update: Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction [Phase 3]

View source ↗

Summary

Phase 3 trial update for LIB003 evaluating long-term efficacy and safety in patients with cardiovascular risk or high cholesterol requiring further LDL-C reduct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Cardiovascular Stroke
• Hypercholesterolemia

Drugs mentioned

• LIB003

Snippet

Sponsor: LIB Therapeutics LLC | Conditions: Cardiovascular Risk Factor, Cardiovascular Diseases | Phase 3 | Status: UNKNOWN